PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Joint Center of Translational Precision Medicine, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, PR China.\', \'The Joint Center of Translational Precision Medicine, Guangzhou Institute of Pediatrics, Guangzhou Women and Children\'s Medical Center, Guangzhou, 510623, PR China.\', \'Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, PR China.\', \'University of Chinese Academy of Sciences, Beijing 100049, PR China.\', \'Hunan Normal University, School of Medicine, Changsha, 410081, PR China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1099/jgv.0.001583
?:doi
?:hasPublicationType
?:journal
  • The Journal of general virology
is ?:pmid of
?:pmid
?:pmid
  • 33956592
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • SARS-CoV-2 replicon for high-throughput antiviral screening.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all